Another gene that was significantly upregulated in cirrhosis compared to healthy controls and NAFLD patients was CHI3L1, which was previously found to be increased in inflammation, promoting angiogenesis, and may have diagnostic value for liver fibrosis [17]. The gene discussed is CHI3L1; the disease is metabolic dysfunction-associated steatotic liver disease.